TABLE 87.1 Characteristics of Human Pathogenic Alphaviruses Virus Epidemiology and Endemic Regions Occurrence and Number of Reported Cases Frequency of Main Symptoms (%) Chikungunya Tropical and subtropical regions of Asia, Africa and Latin America Large sporadic epidemics Fever: 90 Rash: 40-50 Myalgia: 90 Arthralgia/arthritis: >95 Sindbis Virus Group Eurasia, Africa, Australia, Oceania; primarily reported from West Russia (“Karelian fever”), Finland (“Pogosta disease”), and Sweden (“Ockelbo disease”) Geographically most widely distributed alphavirus (lack of data on human cases) Karelian fever: rare (no data) Pogosta disease: 140 cases (range 1-1282)/year Ockelbo disease: 30 cases/year Fever: 15-40 Rash: 90 Myalgia: 50 Arthralgia/arthritis: 95 Ross River Australia, Papua New Guinea, West Papua 5000 cases per year in Australia; in 1979-1980 an epidemic with >60000 cases hit some pacific islands (New Caledonia, Fiji, Samoa, Cook Islands) Fever: 20-60 Rash: 40-60 Myalgia: 40-80 Arthralgia/arthritis: 80-100 Barmah Forest Australia 2000 cases/year Fever: 50 Rash: 40-60 Myalgia: 50-80 Arthralgia or arthritis: 70-95 O’Nyong Nyong East Africa Rare epidemics; >2 million cases in 1959-1961 Fever: 80-100 Rash: 70-90 Myalgia: 70 Arthralgia/arthritis: 60-100 Mayaro South America, primarily the Amazonian rainforest, Caribbean Sporadic single cases and small outbreaks (involving 10-100 cases) Fever: 100 Rash: 30-50 Myalgia: 75 Arthralgia/arthritis: 50-90 Adapted from Suhrbier, A., Jaffar-Bandjee, M.C., Gasque, P., 2012. Arthritogenic alphaviruses-an overview. Nat Rev Rheumatol, 8(7):420-9. 243
====
TABLE 87.2 Results of the Serological Testing for Alphavirus Infections Performed in Our Case Blood Sample Taken on 29 August Blood Sample Taken on 12 September Virus IgM-IFA IgG-IFA PRNT IgM-IFA IgG-IFA PRNT Interpretation of test result Mayaro 1280256040402560160 positive Sindbis <20160 <20 <20160 <20 negative Chikungunya <20160 n.d. <20160 n.d. negative Ross River <20160 n.d. <20160 n.d. negative Barmah Forest <2020 n.d. <2020 n.d. negative IFA: indirect immunofluorescence assay (screening assay) PRNT: plaque reduction neutralization test (confirmatory assay) n.d.: not done (screening assay negative [and epidemiologically not supported]) 244